NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

AIDS Vaccine Week


Susan Hasty, Publisher
Table of Contents . . . October 5th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in AIDS Vaccine Week | Other Publications

HIV/AIDS - Reports summarize HIV/AIDS study results from University of Ulsan, Medical Department

Vaccinia Virus - New findings from J. Delaloye and co-authors describe advances in vaccinia virus

Cancer Vaccines - Data on cancer vaccines described by researchers at London School of Hygiene and Tropical Medicine

HIV/AIDS Genetics - New research on HIV/AIDS genetics from Third Military Medical University, Department of Epidemiology summarized

Immunization - Reports outline immunization study results from University of Pennsylvania

 Biotech Business - Variation Biotechnologies Names Jeff Baxter CEO

Emory University - HIV uses several strategies to escape immune pressure

HIV/AIDS - AVAC Praises Thai AIDS Vaccine Trial Collaborators and Volunteers for Historic Study

HIV/AIDS - HIV Vaccine Study First to Show Some Effectiveness in Preventing HIV

NanoViricides, Inc. - NanoViricides, Inc. Signs a Master Service Agreement with Southern Research Institute for further Influenza and HIV Studies

VaxGen, Inc. - VaxGen Congratulates HIV Prime-Boost Vaccine Study Collaborators and Clarifies Commercial Rights


Return to Top of Page

-----------------------
Home | Free Newsletters | Products | Article Library | About Us | Contact | Privacy Policy | Search | Visit VerticalNews.com
Copyright © 2009 NewsRx		 PR Login